Summary
Laser treatment of benign prostatic hyperplasia has enjoyed growing popularity among urologists over the last few years. Various applicators and techniques have been reported. Because this may result in a different overall performance, we performed a prospective randomized study comparing the results of treatment using the Ultraline fiber (n=44) with that using the Urolase fiber (n=49). Although different types of fibers and techniques were used, the results of this study were surprisingly similar for both fibers used. The uroflow for the Ultraline group increased from an average of 7.9 ml/s at baseline to 19.3 ml/s at 3 months and 16.9 ml/s at 6 months. In the patients treated with the Urolase fiber the uroflow improved from an average of 7.8 ml/s at baseline to 19.5 and 16.3 ml/s at 3 and 6 months, respectively. The improvement in symptoms, reflected by changes in the I-PSS symptom scores, for the Ultraline group went from 21.0 at baseline to 7.9 at 3 months and 6.0 at 6 months. The Urolase patients improved from 21.0 at baseline to 8.2 and 5.6 at 3 and 6 month, respectively. The morbidity mainly consisted of a prolonged need for posttreatment catheterization and irritative symptoms lasting for about 2–4 weeks. From this study we conclude that the results achieved by laser treatment of the prostate using the Ultraline and Urolase fibers are both equivocal and excellent; however, the morbidity of these treatments remains considerable.
Similar content being viewed by others
References
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee (1989) Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 141:243–247
Oesterling JE (1993) Stenting the male urinary tract: a novel idea with much promise. J Urol 150:1648–1649
Schulman CC, Zlotta AR, Rasor JS, Hourriez L, Noel JC, Edwards SD (1993) Transurethral needle ablation (TUNA): safety, feasability and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 24:415–423
Madersbacher S, Kratzik C, Szabo N, Susani M, Vingers L, Marberger M (1993) Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. Eur Urol 23 [Suppl 1]:39–43
Devonec M, Berger N, Perrin B (1991) Transurethral microwave heating of the prostate or from hyperthermia to thermotherapy. J Endourol 5:129–136
Kabalin J (1993) Laser prostatectomy performed with a right angle firing Nd-YAG laser fiber at 40 Watts power setting. J Urol 150:95–99
Norris JP, Norris DM, Lee RD, Rubenstein MA (1993) Visual laser ablation of the prostate: clinical experience in 108 patients. J Urol 150:1612–1614
Narayan P, Fournier G, Indudhara R, Leidich R, Shinohara K, Ingerman A (1994) Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Urology 43:813–820
Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J (1992) Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 69:603–608
Takahashi S, Homma Y, Minowada S, Aso Y (1994) Transurethral ultrasound-guided laser-induced prostatectomy (TULIP) for benign prostatic hyperplasia: clinical utility at one-year follow up and imaging analysis. Urology 43:802–808
Watson G, Anson K, Janetschek G, Horninger W, Bartsch G (1994) An in-depth evaluation of contact laser vaporisation of the prostate. J Urol 151:231A
Rosette JJMCH de la, Froeling FMJA, Alivizatos G, Debruyne FMJ (1994) Laser ablation of the prostate: experience with an ultrasound guided technique and a procedure under direct vision. Eur Urol 25:19–24
Leach GE, Sirls L, Ganabathi K, Roskamp D, Dmochowski R (1994) Outpatient visual laser-assisted prostatectomy under local anesthesia. Urology 43:149–153
Childs S, Alabaster AL, Cowles RS, Dixon C, Kabalin JL, Lepor H, Stein E, Zabbo A (1993) Prospective randomized study comparing transurethral resection of the prostate to visual laser ablation of the prostate. J Urol 149:467A
Anson KM, Watson G (1993) Lasers in the treatment of benign prostatic hyperplasia. In: Puppo P (ed) Contemporary BPH management. Monduzzi editore, Bologna, pp 91–101
Shanberg AM, Lee IS, Tansey LA, Sawyer DE (1994) Extensive neodymium-YAG photoirradiation of the prostate in men with obstructive prostatism. Urology 43:467–471
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de la Rosette, J.J.M.C.H., te Slaa, E., de Wildt, M.J.A.M. et al. Experience with the Ultraline and Urolase laser fibers: is there any difference?. World J Urol 13, 98–103 (1995). https://doi.org/10.1007/BF00183622
Issue Date:
DOI: https://doi.org/10.1007/BF00183622